Repro Med Systems Inc. Common Stock
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
KRMD Overview
Sector |
Health Care |
Industry |
Medical/Dental Instruments |
Previous Close |
$2.9300 |
Previous Close Volume |
64000 |
Latest News
-
KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference
25 Nov 2024 16:27:43
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance
13 Nov 2024 16:27:33
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Participate in Upcoming Investor Conferences
06 Nov 2024 16:17:57
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion
31 Oct 2024 16:18:13
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024
23 Oct 2024 16:27:44
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
05 Sep 2024 07:02:52
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
07 Aug 2024 16:27:57
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
25 Jul 2024 16:12:41
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
24 Jul 2024 16:12:49
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
17 Jul 2024 16:12:43
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
02 Jul 2024 07:28:22
https://www.korumedical.com/investors/news-events/press-releases
-
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
05 Jun 2024 09:28:01
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
04 Jun 2024 16:28:03
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
14 May 2024 16:12:56
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
01 May 2024 16:13:10
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
17 Apr 2024 07:13:13
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
11 Apr 2024 16:13:12
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
18 Mar 2024 17:43:22
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
13 Mar 2024 16:13:26
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
11 Mar 2024 16:13:29
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
06 Mar 2024 07:13:10
https://www.korumedical.com/investors/news-events/press-releases
-
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
21 Feb 2024 07:28:21
https://www.korumedical.com/investors/news-events/press-releases